Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease collagen disease
Phenotype C0034735|raynaud\'s phenomenon
Sentences 9
PubMedID- 26421308 When used together, autoantibodies and capillaroscopic findings are generally accepted as a powerful diagnostic tool for detecting emerging connective tissue diseases (ctds) in patients with raynaud's phenomenon [3–7].
PubMedID- 22883334 Objective: to observe nailfold capillary changes in a cohort of connective tissue disease (ctd) with raynaud's phenomenon (rp) and to explore the diagnostic value of nailfold video-capillaroscopy (nvc) in systemic sclerosis (ssc).
PubMedID- 26016221 Secondary raynaud's phenomenon is common with rheumatic diseases (systemic sclerosis, systemic lupus erythematosus, primary sjogren's syndrome, mixed connective tissue disease, etc.), occlusive vascular diseases, hematologic disorders, use of vibrating tools and use of some medications, and rarely with malignancy.
PubMedID- 24517537 Objectives: nailfold capillaroscopy (nc) and laboratory tests for antinuclear antibodies (ana) are routinely used in parallel for detection of emerging connective tissue disease (ctd) in patients with raynaud's phenomenon (rp).
PubMedID- 24016612 Clinical applicability of quantitative nailfold capillaroscopy in differential diagnosis of connective tissue diseases with raynaud's phenomenon.
PubMedID- 21875018 Capillaroscopy as a prognostic tool for the development of connective tissue disease in patients with raynaud's phenomenon.
PubMedID- 24910968 Nailfold capillaroscopy is also commercially available, with significant published literature that supports its use for detecting microangiopathy secondary to specific connective tissue diseases in patients with raynaud's phenomenon.
PubMedID- 22077618 Sarpogrelate hydrochloride (sarpogrelate) is a selective 5-ht(2a) antagonist and was supposed to be effective for raynaud's phenomenon with collagen disease.
PubMedID- 20194444 Thumb involvement in raynaud's phenomenon as an indicator of underlying connective tissue disease.

Page: 1